Royalty Pharma plc - Class A Ordinary Shares, par value $0.0001 per share (RPRX)

CUSIP: G7709Q104

Q4 2020 13F Holders as of 31 Dec 2020

Type / Class
Equity / Class A Ordinary Shares, par value $0.0001 per share
Shares outstanding
424,966,351
Total 13F shares
226,132,987
Share change
+38,886,110
Total reported value
$11,317,812,164
Put/Call ratio
228%
Price per share
$50.05
Number of holders
188
Value change
+$1,961,711,795
Number of buys
146
Number of sells
48

Quarterly Holders Quick Answers

What is CUSIP G7709Q104?
CUSIP G7709Q104 identifies RPRX - Royalty Pharma plc - Class A Ordinary Shares, par value $0.0001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Royalty Pharma plc - Class A Ordinary Shares, par value $0.0001 per share (RPRX) as of Q4 2020

As of 31 Dec 2020, Royalty Pharma plc - Class A Ordinary Shares, par value $0.0001 per share (RPRX) was held by 188 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 226,132,987 shares. The largest 10 holders included ADAGE CAPITAL PARTNERS GP, L.L.C., FMR LLC, MORGAN STANLEY, Vantage Consulting Group Inc, Capital International Investors, HARVARD MANAGEMENT CO INC, BlackRock Inc., SIGULER GUFF ADVISERS, LLC, JPMORGAN CHASE & CO, and WELLINGTON MANAGEMENT GROUP LLP. This page lists 188 institutional shareholders reporting positions in this security for the Q4 2020 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.